Form 4 for CRMD CorMedix Inc.
Accepted 2025-09-11 00:00:00 ET · period of report 2025-09-09 · accession 0001213900-25-087014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-09-11 | 2025-09-09 | CRMD | Zelnick Kaufman Beth | CLO | S - Sale+OE | $13.41 | -50.0K | 180.4K | -22% | -$670.3K |
| D | 2025-09-11 | 2025-09-09 | CRMD | Zelnick Kaufman Beth | CLO | M - OptEx | $3.30 | +50.0K | 230.4K | +28% | +$165.0K |
| D | 2025-09-11 | 2025-09-09 | CRMD | Zelnick Kaufman Beth | CLO | M - OptEx | $0.00 | -50.0K | 150.0K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-09 | S | D | 49,600 | $13.41 | 180,818 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $12.83 to $13.82. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 2 | Common | Common Stock | 2025-09-09 | M | A | 50,000 | $3.30 | 230,418 | D | — | — | |
| 3 | Common | Common Stock | 2025-09-09 | S | D | 400 | $12.82 | 180,418 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy Common Stock) | 2025-09-09 | M | D | 50,000 | $0.00 | 150,000 | D | $3.30 · — to 2033-12-11 | 50,000 Common Stock | (F2) These options were granted on 12/12/2023. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date. |